profit from every ₹100 of sales.
₹0₹100
Jupiter Life Line Hospitals
₹283.50-0.63% today
+401.8% in 1 year
1-year low ₹48.001-year high ₹332.30
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹47.81 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Jupiter Life Line Hospitals sold, what it kept, and what it did with the cash.
Sales went from ₹8.93 billion in 2023 to ₹15.0 billion in 2026, with ₹1.94 billion of profit last year.
SalesProfit
Jupiter Life Line Hospitals vs. similar companies
Jupiter Life Line Hospitals grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Jupiter Life Line Hospitals | 47.8× · Expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads Jupiter Life Line Hospitals's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 8,925 | 10,695 | 13,024 | 14,998 | |
| 7,114 | 8,555 | 10,469 | 12,125 | |
| 1,638 | 2,014 | 2,430 | 2,556 | |
| 2,060 | 2,605 | 3,285 | 3,807 | |
| 729 | 1,766 | 1,920 | 1,944 | |
| 11.12 | 28.44 | 29.47 | – | |
| 79.7% | 80.0% | 80.4% | 80.8% | |
| 18.4% | 18.8% | 18.7% | 17.0% | |
| 8.2% | 16.5% | 14.7% | 13.0% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 9,855 | 12,813 | 19,049 | 23,831 |
| Cash | 1,345 | 230 | 3,683 | 548 |
| Total debt | 4,686 | 0 | 3,931 | 5,842 |
| Total liabilities | 6,216 | 1,126 | 5,486 | 8,390 |
| 3,657 | 11,690 | 13,562 | 15,441 | |
| 66 | 62 | 65 | – | |
| 15.9% | 14.7% | 12.3% | 10.9% | |
| 19.9% | 15.1% | 14.2% | 12.6% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 1,172 | 1,145 | 2,667 | 2,677 | |
| 772 | 853 | 3,276 | 5,018 | |
| 399 | 292 | -608 | -2,341 | |
| Dividends paid | 51 | 57 | 66 | 66 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 47.8×
- –
- –
- 5.6×
- 6.2×
- –
- 25.8×
- -2.5%
- 2.1%
- 0.1%
Profitability
- 80.8%
- 17.0%
- 13.0%
- –
- 10.3%
- 12.8%
- –
- –
- –
- –
Growth
- +18.9%
- –
- –
- –
- −0.2%
Financial health
- 1.4×
- 0.38
- –
- 9.0×
- 3.02
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 28%of 952
Top 29%of 884
Bottom 23%of 601
Top 29%of 887
Bottom 26%of 987
0.1%of the share price, paid each year
On $1,000 invested$1a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
3.4% of its profit
Room to growStretchedMore than it earnsNews
Jupiter Neurosciences announces pricing of $2M registered direct offeringSeeking Alpha · Aug 21, 2026The newest story we have is from Aug 21, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
50No pass
Benjamin Graham
46No pass
Philip Fisher
53No pass
Peter Lynch
80Pass
Joel Greenblatt
10No pass
Charlie Munger
43No pass
Terry Smith
37No pass
Questions about Jupiter Life Line Hospitals
Is Jupiter Life Line Hospitals a good stock to buy?
A solid business, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Jupiter Life Line Hospitals AI analysis
What does Jupiter Life Line Hospitals do?
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. It is in Medical Care Facilities, based in Mumbai, India.
Does Jupiter Life Line Hospitals pay a dividend?
Yes. At today's price the dividend is 0.1% a year, about 3% of its yearly profit. In 2026 it paid out ₹65.6 million in dividends.
Is Jupiter Life Line Hospitals stock halal?
Yes. Jupiter Life Line Hospitals passes our halal screen: its business is permitted and its debt is 6% of its market value, under the 30% limit. How we check
How has Jupiter Life Line Hospitals stock done over the past year?
Up 401.8% over the past twelve months, to ₹283.50. It traded between ₹48.00 and ₹332.30 and is 14.7% below its high.
Who are Jupiter Life Line Hospitals's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Jupiter Life Line Hospitals's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.